RXRX gains 5.5% in a month on positive pipeline update; long-term hold advised given strong potential of its AI-driven drug discovery platform.

Recursion Pharmaceuticals stock jumps after securing full rights to REV102, aiming to fast-track the first oral therapy for hypophosphatasia.

The technology is already transforming the industry — and could forever change the entertainment we consume. But the battle ...

Former Google CEO Eric Schmidt warns that Artificial Superintelligence (ASI), surpassing human intelligence, is imminent. He ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

The new season will be released in three parts, all around holiday weekends: Volume 1 on Nov. 26 (consisting of four episodes), Volume 2 on Christmas (three episodes) and The Finale on New Year’s Eve.

Eric Schmidt warns society is unprepared for the rapid arrival of Artificial Superintelligence. He highlights significant ...

New research has cast doubt on whether today's advanced artificial intelligence models are truly capable of deep reasoning.

James Gunn's "Superman" has flown into theaters. Where does it rank among the best DC movies of the century so far?

Investing.com -- Morgan Stanley (NYSE:MS) initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals ... for potential partnerships ...